Screener
Castle Biosciences CSTL Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Castle Biosciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-031263
FAQ
- What is Castle Biosciences's current ratio?
- Castle Biosciences (CSTL) reported current ratio of 6.7× in Q1 2026.
- How has Castle Biosciences's current ratio changed year-over-year?
- Castle Biosciences's current ratio decreased by 28.0% year-over-year, from 9.4× to 6.7×.
- What is the long-term trend for Castle Biosciences's current ratio?
- Over 5 years (2020 to 2025), Castle Biosciences's current ratio has grown at a -23.9% compound annual growth rate (CAGR), from 20.6× to 5.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Castle Biosciences's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude